AstraZeneca and GSK slide as Trump and RFK appoint new FDA vaccine chiefProactive Investors • 05/07/25
Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to SayZacks Investment Research • 04/29/25
AstraZeneca Q1 Earnings Rise, But China Drug Allegations May Lead To $8 Million PenaltyBenzinga • 04/29/25
AZN Q1 Earnings Beat, Stock Down on Soft Sales Performance of Key DrugsZacks Investment Research • 04/29/25
AstraZeneca Beat Earnings Views, But Sales Come In Light As Cancer Study FlopsInvestors Business Daily • 04/29/25
AstraZeneca to keep 2025 forecast if US pharmaceutical tariffs in line with other sectorsReuters • 04/29/25
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACRPRNewsWire • 04/28/25
Unveiling Astrazeneca (AZN) Q1 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 04/24/25
Tempus AI shares jump on new oncology AI partnerships with AstraZeneca, PathosProactive Investors • 04/23/25
Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in OncologyBusiness Wire • 04/23/25
AstraZeneca CEO says Europe must protect its health sovereignty, is falling behind on pharma investmentsReuters • 04/23/25
Astrazeneca (AZN) Rises But Trails Market: What Investors Should KnowZacks Investment Research • 04/22/25
AstraZeneca reports best trial results in a decade for metastatic breast cancer treatmentProactive Investors • 04/22/25
Should You Buy, Sell or Hold AstraZeneca Stock Before Q1 Earnings?Zacks Investment Research • 04/21/25